Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Indoline | HCID 10328 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Triphosgene | HCID 94429 | — |
| Reactant | HCID 178478587 | HCID 178478587 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 178523688 | HCID 178523688 | 68.1% |
Reaction Steps
To a stirred mixture of N-trans-4-[2-(4-Benzo[1,3]dioxol-4-yl-piperazin-1-yl)-ethyl]-cyclohexylamine hydrochloride (Intermediate A) (31.1 mg, 85 μmol) in DCM (1 ml) at room temperature N,N-diisopropylethylamine (110 mg, 148 μl, 850 μmol, Eq: 10) and triphosgene (27.7 mg, 93.5 μmol, Eq: 1.1) was added carefully and the solution stirred for minutes at room temperature. Indoline (12.2 mg, 102 μmol, Eq: 1.2) was added and stirred for 30 minutes at room temperature. The reaction mixture was quenched with 10 mL sat NaHCO3 and extracted with DCM (3×15 mL). The organic layers were dried over MgSO4 and concentrated in vacuo. The crude material was purified by flash chromatography (silica gel, 100 g, 0% to 10% MeOH in DCM) to yield the title compound as an white solid (27.6 mg, 68.1%), MS (ISP) m/z=477.2 [(M+H)+].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08722683B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-a27be01a6f4646c091b2c1a0391e4a2b |
|---|
| Source note | uspto-grants-2014_05 |
|---|